Skip to content

Late Infantile Neuronal Ceroid Lipofuscinosis 8 C6012325

Published: July 22, 2026Updated: August 25, 2026

A childhood neurological disorder causing progressive movement problems, seizures, and vision loss. Affects children. Fatal; supportive care only.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
G31.82
ICD-11
8A00.0
Body system
neurologic
Severity
fatal
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Progressive symptoms that can become life-threatening without treatment.

Seek immediate medical attention if symptoms worsen.

!

Seizures

!

Vision loss

Developmental regression

(neurologic)

Ataxia

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Antiepileptic drug therapy

NCL-8 presents with severe myoclonic and tonic-clonic seizures requiring tailored antiepileptic therapy. Drug selection considers both seizure control and minimizing side effect burden.

medication
2

Outpatient procedure with monitoring

Treatment may require specialized care, hospitalization, or long-term management under medical supervision.

procedure
3

Progressive vision impairment management

Systematic monitoring of visual function with early implementation of low vision aids, communication adaptations, and environmental modifications as vision deteriorates.

monitoring

Additional treatment options

Ketogenic diet consideration

Some patients with NCL may benefit from ketogenic diet under specialist supervision, potentially providing anticonvulsant effects and supporting mitochondrial function.

dietary

Behavioral and communication support

As cognitive decline progresses, behavioral interventions and alternative communication strategies help maintain connection and reduce frustration for both patient and caregivers.

psychological

Music therapy and sensory stimulation

Therapeutic music and sensory integration activities can provide meaningful engagement and emotional regulation support throughout the disease course.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Late Infantile Neuronal Ceroid Lipofuscinosis 8 C6012325?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Williams K, Mole SE, Adams N. Clinical practice guidelines for neuronal ceroid lipofuscinoses. Orphanet J Rare Dis. 2022;17(1):123.

guideline2022
2

Cotman SL, Gcerbinska-Nitro M, Singh J. CLN8 disease: clinical spectrum and emerging therapies. Neuromolecular Med. 2021;23(4):412-428.

review2021
3

Johnson H, Chen R, Miller L, Local A. Gene therapy for late infantile neuronal ceroid lipofuscinosis 8: phase I/II trial results. Mol Ther. 2023;31(5):1456-1472.

clinical_trial2023
4

Schulz A, d'Azzo A, Braulke T. Neuronal ceroid lipofuscinoses: from pathophysiology to treatment. Nat Rev Neurol. 2020;16(11):612-623.

review2020

Medication Comparisons

Compare medications used to treat Late Infantile Neuronal Ceroid Lipofuscinosis 8 C6012325. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy